Skip To Main Content

Our Neuroscience Portfolio

Find product and prescribing information, as well as other resources, for Genentech’s neuroscience portfolio below.

A

Activase®

(alteplase)

Prescribing Information

Safety Data Sheets:

ACTIVASE® Vials (50 mg)
ACTIVASE® Vials (100 mg)

Healthcare Provider Letter:

Stopper Dislodgement - How To Reduce the Risk of Stopper Dislodgement and Leakage When Using 100-mg Vials

E

Enspryng®

(satralizumab-mwge)

Prescribing Information
Medication Guide

Safety Data Sheets:

ENSPRYNG® SC (120 mg/mL)

Evrysdi®

(risdiplam)

Prescribing Information
Important Patient Information
Instructions For Use

Safety Data Sheets:

EVRYSDI® Powder for Oral Solution (60 mg)
EVRYSDI® (risdiplam) 0.75 mg/mL

Healthcare Provider Letter:

Information Regarding Potential Leakage of Evrysdi (risdiplam) 0.75 mg/mL NDC 50242-175-07 Solution from Bottles Delivered to Patients

O

Ocrevus®

(ocrelizumab)

View Product Page

Ocrevus Zunovo™

(ocrelizumab and hyaluronidase-ocsq)

View Product Page
Publications icon

Publications

Visit PubMed.gov to view scientific literature for Genentech neuroscience portfolio products.

Activase® at PubMed.gov

Enspryng® at PubMed.gov

Evrysdi® at PubMed.gov

Scientific congresses icon

Scientific Congresses

Genentech maintains a presence at in-person and virtual scientific congresses worldwide. Find Genentech-sponsored posters and presentations from recent congresses at Medically.gene.com.

Clinical trials icon

Clinical Trials

Find information about active clinical research for Genentech neuroscience portfolio products.

Activase® at ClinicalTrials.gov

Enspryng® at ClinicalTrials.gov

Evrysdi® at ClinicalTrials.gov

Additional resources icon

Additional Resources

Connect with a Medical Science Liaison

Browse the Genentech Medical Information Library